Reactivation of telomerase in cancer

Cell Mol Life Sci. 2016 Apr;73(8):1659-70. doi: 10.1007/s00018-016-2146-9. Epub 2016 Feb 4.


Activation of telomerase is a critical step in the development of about 85 % of human cancers. Levels of Tert, which encodes the reverse transcriptase subunit of telomerase, are limiting in normal somatic cells. Tert is subjected to transcriptional, post-transcriptional and epigenetic regulation, but the precise mechanism of how telomerase is re-activated in cancer cells is poorly understood. Reactivation of the Tert promoter involves multiple changes which evolve during cancer progression including mutations and chromosomal re-arrangements. Newly described non-coding mutations in the Tert promoter region of many cancer cells (19 %) in two key positions, C250T and C228T, have added another layer of complexity to telomerase reactivation. These mutations create novel consensus sequences for transcription factors which can enhance Tert expression. In this review, we will discuss gene structure and function of Tert and provide insights into the mechanisms of Tert reactivation in cancers, highlighting the contribution of recently identified Tert promoter mutations.

Keywords: Cancer; NF-κB; TERT reactivation; Tert promoter mutation; Transcription.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Enzyme Activation / physiology
  • Epigenesis, Genetic
  • Humans
  • Mutation / genetics
  • Neoplasms / genetics
  • Neoplasms / pathology*
  • Promoter Regions, Genetic / genetics*
  • Telomerase / genetics*
  • Telomerase / metabolism*


  • TERT protein, human
  • Telomerase